Prescription drug · UNAPPROVED DRUG OTHER
Phenobarbital NDC 13517-625
Phenobarbital 16.2 mg/1 · Tablet · Oral · e5 Pharma, LLC
NDC codes
FDA NDC DirectoryProduct NDC (as listed)13517-625Labeler and product segments. Claims need a package NDC.
Product NDC at billing width13517-0625Add the package segment from the table below.
Product information
- Brand name (proprietary)
- Phenobarbital
- Generic name (nonproprietary)
- phenobarbital
- Active ingredients
- Phenobarbital — 16.2 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- e5 Pharma, LLC
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Marketing end
- DEA schedule
- CIV
- Identifiers
- Product ID 13517-625_326d57e5-b0f8-439f-abd6-186f241e01acSPL ID 326d57e5-b0f8-439f-abd6-186f241e01acSPL set ID 884f7b62-160a-46c3-92d4-1031b255b76cRxCUI 198086, 199164, 199167, 199168UNII YQE403BP4DUPC 0313517625018, 0313517628019, 0313517627012, 0313517626015
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Sedative Anticonvulsant – For the treatment of generalized and partial seizures.
Excerpt only. Read the full label for complete information.